DHEA supplementation of systemic glucocorticoids for treatment of poison ivy dermatitis.
Geracioti
Thomas D
TD
D000284:Administration, Oral; D000328:Adult; D003687:Dehydroepiandrosterone / Q000627:therapeutic use*; D011040:Dermatitis, Toxicodendron / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D016896:Treatment Outcome
D005938:Glucocorticoids; D003687:Dehydroepiandrosterone